Results for “”

Entry Author Date Location
Lundbeck’s Alder Bio Bet Pays Off With FDA Approval of Migraine Drug 02/23/20 National
Bio Roundup: Agile Approval, Coronavirus Collabs, Spruce’s $88M & More 02/21/20 National
SeaGen Adds Five Prime Therapeutics Antibodies in Licensing Deal 02/20/20 Seattle
Spruce Bio Raises $88M for Clinical Tests of Rare Endocrine Disease Drug 02/20/20 San Francisco
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device 02/19/20 Boston
Teva Drug Fails to Beat Placebo in Pediatric Tourette Patient Trials 02/19/20 National
Xcelerating Life Sciences Boston Will Explore Biopharma’s Future in Digital Health 02/19/20 Boston
ResTORbio Pins “Strategic Alternatives” Pitch to Parkinson’s Promise 02/19/20 Boston
Five Prime, Bristol Pancreatic Cancer Drug Combo Fails Phase 2 Test 02/18/20 San Francisco
Imara Reveals IPO Plan as Sickle Cell Drug Advances in the Clinic 02/18/20 Boston
New Meds Set to Reshape US CNS and Oncology Markets 02/18/20 National
Agile Therapeutics Wins FDA Nod for Twirla Contraceptive Patch 02/14/20 New York
Bio Roundup: Goodbye Belviq, LogicBio on Hold, Revolution’s IPO & More 02/14/20 National
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks 02/13/20 National
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer 02/12/20 San Francisco
Ligand’s Icagen Deal Brings Neuro, CF Assets Plus Partnering Potential 02/12/20 San Diego
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019 02/12/20 National
Two Big Pharma Alliances End in Nixed Deals. Here’s What Happened. 02/11/20 National
FDA Clinical Hold Stops LogicBio’s Gene Editing Study Before It Starts 02/10/20 Boston
Wave Life Sciences’ Stumble in Duchenne Leads to 22% Staff Layoff 02/10/20 Boston
Biohaven Drug Fails Anxiety Study, Data in OCD and More Still to Come 02/10/20 New York
Eli Lilly, Roche Drugs Fail to Move Needle in Genetically Driven Alzheimer’s 02/10/20 National
Bio Roundup: POTUS on Prices, a16z’s Fund, Aimmune’s Approval & More 02/07/20 National
Sonoma Bio Launches With $40M to Take Cell Therapy Beyond Cancer 02/06/20 San Francisco
Scripps Research’s Calibr to Test “Switchable” CAR-T in Clinical Trial 02/06/20 San Diego
Early Bird Sale Ending for San Diego’s Xcelerating Life Sciences Conference 02/06/20 National
Beam Therapeutics IPO Raises $180M After Nearly Doubling Shares Offered 02/06/20 Boston
Coda Bio Acquires Drug Candidates to Pair With Engineered Receptors 02/06/20 San Francisco
Aimmune Gets $200M From Nestlé; Licenses Food Allergy Drug Candidate 02/05/20 San Francisco
Merck Charts an R&D-Focused Course Starting With a $6.5B Spinoff 02/05/20 New York
Page 1 of 1960 next page »